Ultrastructural data from 108 species of Chrysomeloidea show that all rhabdom‐patterns can be assigned to one of two basic patterns. The insula‐pattern: two central rhabdomeres (Rh 7/8) are spatially isolated from the six peripheral ones (Rh 1–6). The ponticulus‐pattern: Rh 7/8 fuse at two sites with the ring of Rh 1–6. The distance between the two systems may prevent optical or electrical coupling in the insula‐p. The structure of the ponticulus‐p may allow electrical coupling as well as contrast‐intensifying lateral filtering. Potential relative polarization and absolute sensitivities differ interspecifically between homologous cells and intraspecifically between Rh7/8 and Rh 1–6, and between Rh 7 and Rh 8. The Bruchidae show only the insula‐p, the Chrysomelidae and Cerambycidae both. The distribution of the two patterns is subfamily‐specific within the Chrysomelidae, but not in the Cerambycidae. Identical patterns must have developed convergently within the Chrysomeloidea. Both basic patterns are subdivided in different subfamilies or tribes.
Prior to authorisation of plant protection products (PPP) according to Regulation (EC) No 1107/2009 it must be ensured that products placed on the market will not impair the health of humans and animals if used appropriately and as intended. For safe use of pesticides, it is generally necessary to assign obligatory instructions for operators to comply with risk mitigation measures. These instructions are allocated due to the intrinsic toxicological properties of the products combined with qualitative exposure aspects, e.g. for different formulation types and application scenarios. The toxicological properties of PPP are evaluated on the basis of the uniform principles according to Regulation (EC) No 1107/2009, and are communicated by the classification and labelling of the products. Additionally, quantitative exposure estimations carried out within the risk assessment for the products might result in additional instructions for safe use. Those instructions aim to ensure, that the respective toxicological reference value will not be exceeded. The latter issue will be addressed in another article. The general principles for assigning mandatory instructions for professional and non-professional operators of PPP concerning human health are based on the classification and labelling of PPP according to Regulation (EC) No 1272/2008 (CLP-Regulation). Plant protection products are classified based on toxicological tests (mainly acute toxicity, irritation and sensitisation) and on conventional methods based on the above mentioned Regulation (mainly for subacute and chronic effects). Since the CLP-Regulation is obligatory for classification and labelling of mixtures such as PPP from 1 June 2015 onwards, it will be necessary to replace BBA uniform principles for safeguarding the health of applicators of plant protection products (1993) Part 1, 3-3 and adapt its principles for assigning PPE and instructions for safe use on the basis of the new classification and labelling principles for products. This article will provide the necessary support for risk management decisions concerning human health. It presents principles to implement, adapt and specify the rather imprecise provisions concerning the use of PPE laid down in CLP-Regulation to the particular requirements for handling and applying PPP. It might be a basis for European harmonisation concerning allocation of risk mitigation measures to professional and non-professional operators of pesticides, thus, adjusting the different levels of operator protection in the Member States, as stated in Regulation (EC) No 1107/2009.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.